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The new multi-modality cardiovascular imaging journal, European Heart Journal - Cardiovascular Imaging, was created in 2012. Here we summarize
the most important studies from the journal’s second year in two articles. Part I of the review has summarized studies in myocardial function,
myocardial ischaemia, and emerging techniques in cardiovascular imaging. Part II is focussed on valvular heart diseases, heart failure,
cardiomyopathies, and congenital heart diseases.
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Introduction
The multi-modality European Heart Journal and Cardiovascular Imaging
has successfully transitioned from an exclusive echocardiographic
journal two years ago. The journal now serves as an important re-
source for general cardiologists, specialists in all imaging modalities,
and other physicians working in the field of cardiovascular imaging.
In two articles, we highlight the most important studies that were
published in the journal in 2013. Part II is focussed on valvular heart
diseases, heart failure, cardiomyopathies, and congenital heart
diseases.
Valvular heart disease
With the growth of the elderly population, valvular heart disease
(VHD) has become an important cause of cardiovascular morbidity
and mortality.1 Multi-imaging modality plays a major role in the diag-
nosis, management, and risk stratification of patients with VHD.2
Doppler echocardiography is crucial to initial and longitudinal assess-
ment of patients with VHD. It provides detailed anatomic and func-
tional information, and clarifies the mechanisms of regurgitation
and the potential for valve repair. Mitral valve prolapse (MVP) is
one of the most frequent valve lesions requiring surgery. Clefts in
the mitral leaflets are known to represent a risk factor for early
failure of mitral valve repair. Ring et al.3 showed that clefts are fre-
quently seen in MVP and may play an important role in the
development of MVP. Lancellotti et al.1 have reported the recom-
mendations for the echocardiographic assessment of native VHD.
The key points were: (i) the evaluation of valvular regurgitation
requires the use of different echocardiographic modalities, including
3D echocardiography, when available; (ii) the evaluation should
integrate multiple parameters to assess its severity—qualitative,
semi-quantitative, quantitative, chronicity of the disease—and
should be combined with clinical data. The assessment of tricuspid
regurgitation (TR) remains challenging because standards for deter-
mining TR severity are less robust than for left-sided valvular
regurgitation. In fact, algorithms for relating colour flow-derived
parameters to TR severity are less well developed. Adjunctive para-
meters may help to consolidate about the severity of TR. Mutlak
et al.4 have reported that excessive respiratory changes in Doppler
measurements of TR systolic velocities (≥0.6 m/s) were a specific
sign of severe TR. Left-ventricular (LV) ejection is known to under-
estimate the extent of intrinsic myocardial dysfunction in patients
with VHD.5 2D speckle-tracking imaging of myocardial deformation
has gained growing interest in VHD and detects more accurately the
presence of subtle LV myocardial dysfunction.6 Layer-specific strain
analysis enables to evaluate myocardial deformation from endocar-
dial to epicardial myocardial layers. Kaneko et al.7 showed that trans-
mural and inner-half strainsbut not outer-half strains were reduced in
patients with chronic severe aortic regurgitation and preserved LV
ejection fraction; these parameters improved after aortic valve
surgery suggesting that they could be used to determine the
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optimal timing for surgery. In patients with primary mitral regurgita-
tion (MR), Witkowski et al.8 reported that the use of contemporary
indication criteria for mitral valve repair (MVr) was associated with a
low incidence of long-term post-operative LV dysfunction. Interest-
ingly, they showed that a reduced pre-operative global longitudinal
strain (GLS:219.9%) emerged as a powerful independent predictor
of post-operative LV systolic dysfunction. In secondary MR, the rela-
tionship between left atrial (LA) function and recurrent MR after MVr
has been poorly investigated. Van Garsse et al.9 observed an irrevers-
ible impairment in LA reservoir function due to reduced compliance
in patients with recurrent MR after MVr. The assessment of LA strain
can beusedas anadditional finding to identifypatientswhoareunlike-
ly to benefit from mitral annuloplasty. Of note, in patients with
chronic primary MR, LA becomes more spherical with increasing se-
verityof MR, suggesting a decrease in LA eccentricity index in relation
to the decreased LA systolic function.10 In aortic stenosis (AS), the
increase in LV afterload does not only result from outflow obstruc-
tion but also from reduced systemic arterial compliance.11 In these
patients, the circumferential ascending aortic strain estimated by
2D speckle tracking is reduced and correlates with stroke volume
index and LV afterload-related variables such as valvulo-arterial im-
pedance and aortic valve area.12 Garcia et al.13 demonstrated in 71
patients with AS that cardiac magnetic resonance (CMR) may be an
alternative to echocardiography, e.g. in patients with poor acoustic
windows, for the evaluation of aortic valve kinetics (valve opening
and closing slope) with low observer variability. Bicuspid aortic
valve (BAV) represents the most frequent congenital cardiac abnor-
mality resulting in premature valvular degeneration and aortic dilata-
tion. Meierhofer et al.14 showed using CMR that wall shear stress and
flow patterns in the ascending aorta in patients with BAVs differ sig-
nificantly from tricuspid aortic valves. The significantly higher shear
stress may have an impact on the development of aortic dilation in
these patients. Infective endocarditis remains a dangerous condition
in which imaging plays a key role. Identification of prosthetic valve
endocarditis (PVE) remains challenging. The use of radiolabelled
leucocyte scintigraphy carries an excellent positive predictive value
for the detection of PVE in patients with inconclusive echocardiog-
raphy.15 Therefore, the intensity of radiolabelled leucocyte accumu-
lation in the perivalvular area represents an interesting marker of
local infectious activity and extension. Selection of candidates for
mitral valve/transcatheter aortic intervention (TAVI) is complex
and often involves a multi-modality imaging strategy. Echocardiog-
raphy is the primary imaging modality used at all stages of the
percutaneous MitraClip and TAVI procedures, complementing
fluoroscopy. This has been elegantly addressed in two review arti-
cles.16 MitraClip therapy has proven successful in reducing the
degree and severity of MR. Whether MR downgrading relates to im-
mediate change in mitral ring geometry is unknown. Schmidt et al.17
showed a significant reduction in mitral annulus size in the antero-
posterior region but not in the latero-medial region after MitraClip
implantation in patients with secondary but not primary MR. Tsang
et al.18 reported that AS can affect the mitro-aortic coupling. More-
over, TAVI does not result in recovery of mitral valve structure/func-
tion as the prosthetic aortic ring compresses the calcified aortic valve
in the aortic-mitral fibrous continuity. These features have implica-
tions in the future TAVI valve development. Maffesanti et al.19 were
able to compare mitral and tricuspid valve morphology and dynamics
in the same patients and in the same conditions using a novel semi-
automatic algorithm based on cine CMR images for point tracking
and 3D reconstruction. The methodology was feasible and accurate
when compared with manual assessment and holds great promise.
VHD and cardiac computed tomography
Coronary computed tomography (CT) angiography (CTCA) may be
considered as an alternative to invasive coronary angiography to rule
out significant coronary artery disease (CAD) before non-coronary
cardiac surgery. An analysis ofCatalanet al.20 was based on the results
of four European studies and indicated that in experienced hands, the
use of initial pre-operative CTCA could have avoided many invasive
coronary angiographies and resulted in a more cost-effective strategy
than the conventional invasive coronary angiography strategy.
Heart failure
In 2013, several studies have addressed the role of imaging in heart
failure (HF). Dobutamine stress echocardiography is widely used to
evaluate the presence and extent of myocardial functional reserve
in HF patients. The relationship between dobutamine-induced
changes in long-axis function as evaluated by tissue Doppler mitral
annular velocities (s′) and exercise capacity was reported by
Ciampi et al.21 The weaker the change, the weaker the contractile re-
cruitment, and the lower the exercise tolerance. LV systolic shorten-
ing velocity was also closely associated with invasive measurements
of cardiac output, whereas changes in E/e′ ratios did not correlate
with pulmonary capillary wedge pressure. This latter observation
warrants some caution in converting changes in E/e′ into changes in
LV filling pressure.22 Conversely, changes in E/e′ during exercise
are well correlated with exercise capacity; E/e′ has greater specificity
for raised filling pressure and could be used to rule out cardiac
reasons as a cause for dyspnoea on exertion.23 Reduced peak
oxygen uptake (peak VO2) is one of the most important predictors
of cardiovascular events in HF. In healthy subjects, coronary flow
reserve (CFR) is well correlated with peak VO2. In HF, CFR, E/e′
and s′ but not traditional measuresof LV systolic function (i.e. LVejec-
tion fraction) are correlated with peak VO2. CFR is thus likely to be a
limiting factor in functional capacity in HF.24 Abnormal glucose me-
tabolism as estimated by oral glucose tolerance testing is also asso-
ciated with reduced LV contractile reserve and exercise tolerance
in HF. Egstrup et al.25 have underscored such an association in 161
patients with systolic HF. This observation may offer one explanation
for the excess mortality related to diabetes in HF. Preliminary data
suggested that the persistence of vortex (echo-contrast particle
image velocimetry) from late diastole into isovolumic contraction
could be a marker of the fluid continuum of the cardiac cycle and
help coupling diastole to systole. The change in vortex strength
may have prognostic value in HF.26 The most frequent clinical mani-
festation of anti-cancer drugs-related cardiotoxicity is symptomatic
or asymptomatic LV dysfunction that can progress to HF.
Anthracycline-induced cardiomyopathy has been associated with
the worst prognosis. Stoodley et al.27 described an immediate alter-
ation in LV diastolic function that correlated with LV systolic dysfunc-
tion after the administration of therapeutic doses of anthracycline
chemotherapy. Therefore, recognition of altered diastolic function
could serve as an indicator of altered LV systolic function, and
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thereby identifying a subset of patients who should benefit from a
closer follow-up. LV dyssynchrony is frequent in HF and largely
affects response to cardiac resynchronisation therapy.28 To date,
no standardized methods have been shown to be superior to
another to evaluate LV dyssynchrony. Beyond differences between
methods, variability could also result from the vendor-specific
software used to estimate the degree of mechanical dispersion. Aly
et al.29 compared TomTec and QLAB software packages for 3D
echocardiographic assessment of LV dyssynchrony including their
ability to predict response to CRT. They concluded that these
3D software packages are not interchangeable; TomTec software
seemed more accurate than QLAB for the prediction of response
to CRT. Obtaining an optimal LV lead position in CRT can be challen-
ging. Shetty et al.30 used CMR to guide LV lead positioning by
overlaying three latest activated segments with ,50% scar on late-
gadolinium enhanced images (LGE) on to live fluoroscopy. Long-
term response to CRT was improved with the use of this technique.
After CRT implantation, long-term survival depends on several
factors; the reduction in LV end-systolic volume is a better predict-
or when compared with the improvement in clinical status.31
However, mechanical radial discoordination rather than mechanical
dyssynchrony carried incremental predictive value over classical
baseline characteristics (i.e. QRS morphology) for response to
CRT.32 LV dyssynchrony can vary during exercise.33 In patients
with LV systolic dysfunction, dynamic LV dyssynchrony is correlated
with dynamic MR and exercise intolerance. In patients with dilated
cardiomyopathy and narrow QRS, the dynamic increase in LV dys-
synchrony during exercise echocardiography also emerged as a
strong predictor of less favourable event-free survival.34
Cardiomyopathy
The measurement of myocardial strain and strain rate can be
obtained by different imaging methods. Interestingly, decreased
strain parameters may identify pre-clinical ventricular dysfunction
at a stage when conventional studies remain normal. Both colour
Doppler myocardial imaging and 2D speckle-tracking analysis have
been used in a series of obese children and adolescents. Compared
with non-obese, sex- and age-matched controls, LV longitudinal
strain by both methods was lower, in the absence of other co-
morbidities, although LV ejection fraction was not different
between the two groups.35 Another study confirmed these findings,
indicating that childhood obesity may be responsible for early
alteration in both longitudinal and circumferential LV strain.36
Myocardial 2D strain echocardiography was measured in children
with acute lymphoblastic leukaemia treated with anthracycline
therapy. All strain parameters—global longitudinal, radial, and cir-
cumferential strains—decreased significantly. N-terminal pro-brain
natriuretic peptide was not related to strain parameters and
cardiac troponin T was not a predictor of abnormal strain 1 year
after anthracyclines, indicating the importance of combining strain
parameters and cardiac biomarkers in this setting.37
In a cohort of children with Kawasaki disease, systolic LV myocar-
dial strain and strain rate were obtained by velocity vector imaging.
Routine echocardiographic measurements were normal. Compared
with controls, patients had lower GLS and strain rate, particularly in
patients with coronary artery dilation and resistance to treatment
with intravenous immunoglobulin.38
The experience with 3D speckle-tracking echocardiography (STE)
is increasing. This method may be a more accurate tool than 2D STE
in particular when a marked translational motion of the heart inside
the chest occurs during the cardiac cycle, such as in transplant
recipients. This was confirmed in a series of 36 heart transplant
recipients. GLS was lower with 3D STE when compared with 2D
STE: the inferolateral wall was a source of variation between the
two methods. 3D—but not 2D STE-derived longitudinal strain—
was independently associated with NYHAclass, suggesting aclinically
relevant relationship between functional status and myocardial
mechanism in these patients.39
The clinical course of patients with hypertrophic cardiomyop-
athy (HCM) can be influenced in part by subendocardial ischaemia
and atrial fibrillation. Myocardial ischaemia is a major cause of
chest symptoms in these patients and its assessment remains
difficult. Subendocardial perfusion abnormality may be reflected
by transient LV cavity dilation during exercise, which can be
quantified by Tc-99m tetrofosmin scintigraphy. The results of this
method have been compared with ultrasonic tissue characteriza-
tion using cyclic variation of integrated backscatter (CV-IB) and
LGE CMR. Right and left halves of the ventricular septum were
analysed. CV-IB in the right halves of the ventricular septum
was predominant in patients with subendocardial ischaemia,
whereas a reverse predominance was observed in patients
without subendocardial ischaemia. LGE CMR was not associated
with subendocardial ischaemia, suggesting that repetitive subendo-
cardial ischaemic episodes did not induce myocardial fibrosis in
patients with HCM.40
The identification of HCM patients at risk of paroxysmal atrial
fibrillation is clinically important. The combination of enlarged
LA antero-posterior diameter, decreased peak strain rate of the LA
lateral wall in the reservoir phase, and a prolonged P-wave duration
in the Z-lead yielded an area under the curse of 0.90 for identifying
patients with documented episode(s) of atrial fibrillation.41
Several characteristics are known to be useful for predicting
cardiac events in HCM patients: HCM-related death, HF, stroke, or
worsening of symptoms. A tissue Doppler imaging study showed
that a short deceleration time of E wave (,197 ms) and a high
septal E/e′ (.9.65) are independent predictors of cardiovascular
events in HCM patients.42
Mitochondrial disease is associated with morphological abnormal-
ities and HF and early detection is important for risk stratification.
Bateset al.43 showed that CMRdetects functional (strainparameters)
and metabolic (measured with MR Spectroscopy) abnormalities in
carriers of the m.3243A.G mutation without known cardiac in-
volvement. Importantly, the mutation load correlated with abnor-
malities, in particular the LV mass index.
The differential diagnosis between Tako-Tsubo cardiomyopathy
(TTC) and acute anterior infarction is challenging before coronary
angiography. Before coronary angiography, left anterior descending
artery distal flow by transthoracic Doppler echocardiography was
visible in all patients with TTC and in only 36% of patients with
acute myocardial infarction. The combination of distal flow and the
pattern of wall motion characteristics provided a diagnostic accuracy
of 86%. In addition, CFR assessedwithin 1 dayafteradmission was less
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severely impaired in the TTC group when compared with the acute
infarction group.44
The development of multi-dimensional flow assessment and
derived estimates of kinetic energy (KE) by CMR is beginning to dem-
onstrate clinical utility. In 10 patients with dilated CM, Erikson et al.45
demonstrated changes in the diastolic flow route in the LV and
changes to inflow KE compared with 10 control subjects. These
observations are potential subclinical markers of LV dysfunction.
Cardiovascular complications of radiotherapy include pericardial,
myocardial, valve, and CADs. The role of multi-modality imaging
has been proposed and reported in the Journal from the European
Association of Cardiovascular Imaging and the American Society of
Echocardiography.46
Congenital heart disease
Multi-modality imaging is essential for the diagnosis and follow-up of
congenital heart disease. A European certification process for echo-
cardiography of congenital heart disease has been endorsed by the
European Association of Cardiovascular Imaging formerly the Euro-
pean Association of Echocardiography, the Association for European
Paediatric and Congenital Cardiology, and the Grown-up Congenital
Heart Working Group of the European Society of Cardiology. The
flowchart of certification includes several steps for candidates: initi-
ation of the process, log of cases, registration for examination, certi-
fication examination, submission of additional documentation, and
confirmation of certification. This process has proved feasible.47
Like echocardiography, CMR has become an essential tool in the
management of patients with congenital heart disease. In addition
to morphological and functional assessment, CMR can demonstrate
myocardial scar and fibrosis and methods for estimation of interstitial
myocardial volume based on T1 mapping have been developed. In
patients with Tetralogy of Fallot (TOF), Munkhammar et al.48
showed with LGE CMR that fibrosis of the RVOT is strongly asso-
ciated with restrictive RV physiology.
Using T1 mapping, Plymen et al.49 reported that in adults who
had undergone atrial redirection surgery for transposition of the
great arteries (TGA), CMR showed interstitial expansion in the in-
terventricular septum compared with age-and sex-matched healthy
volunteers. Although it was not possible to measure the interstitial
volume of the right ventricle in this study, its findings go some
way in explaining the long-term consequences of atrial redirection
surgery.
Although anatomic correction of complete TGA by arterial switch
operation is successful, a significant proportion of patients have
impaired exercise capacity. Dynamic changes in LV contractility
have been assessed by the measurement of LV myocardial isovolumic
acceleration at rest and at different heart rates during exercise,
leading to the determination of LV force–frequency relationship
(FFR). The curve of patients was shown to be flattened compared
with a positive FFR reference curve observed in a healthy paediatric
cohort. LV contractile reserve was worse in patients having variant
coronary arterial anatomy.50
Patients with hypoplastic left heart syndrome may require
tricuspid valve repair for correcting tricuspid valve insufficiency, a
consequence of important structural abnormalities of the valve.
Although 2D echocardiography can identify several of these
abnormalities, echocardiography is sensitive to detect leaflet
motion abnormalities but not leaflet structural abnormalities,
leading to significant discrepancies between echocardiographic and
surgical findings.51
Right atrial anatomy is complex. Catheter-based interventions for
right atrial structural or electrical disorders require a good under-
standing of right atrial anatomy. Anatomical details can be provided
by 3D transoesophageal echocardiography, cardiac computed
tomography or magnetic resonance imaging. A review article has
described the normal anatomy and variants of right atrial struc-
tures.52 Another review article has described the peri-interventional
echocardiographic assessments for device closure of interatrial com-
munications. Intracardiac echocardiography is safe and spares the
patient the risks and discomfort of general anaesthesia, but the
costs of catheters remain an important limitation.53
Conclusion
This review has summarized the studies in VHDs, HF, cardiomyop-
athies, and congenital heart diseases published in 2013 in the
European Heart Journal - Cardiovascular Imaging.
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